Carl Zeiss Meditec AG Stock Mexican S.E.

Equities

AFX N

DE0005313704

Advanced Medical Equipment & Technology

End-of-day quote Mexican S.E. 07:00:00 2023-03-15 pm EDT 5-day change 1st Jan Change
3,258 MXN -.--% Intraday chart for Carl Zeiss Meditec AG -.--% -.--%

Financials

Sales 2024 * 2.23B 2.43B 43.42B Sales 2025 * 2.51B 2.73B 48.81B Capitalization 7.51B 8.17B 146B
Net income 2024 * 255M 277M 4.96B Net income 2025 * 312M 339M 6.07B EV / Sales 2024 * 3.54 x
Net Debt 2024 * 396M 431M 7.7B Net Debt 2025 * 345M 375M 6.71B EV / Sales 2025 * 3.13 x
P/E ratio 2024 *
29.5 x
P/E ratio 2025 *
23.8 x
Employees 4,950
Yield 2024 *
1.26%
Yield 2025 *
1.42%
Free-Float 40.86%
More Fundamentals * Assessed data
Dynamic Chart
3 years
3 258.20
Extreme 3258.2
4 720.85
5 years
3 258.20
Extreme 3258.2
4 720.85
10 years
3 258.20
Extreme 3258.2
4 720.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 21-12-30
Director of Finance/CFO 59 18-09-30
Director/Board Member 57 09-12-14
Members of the board TitleAgeSince
Director/Board Member 67 01-12-31
Chairman 60 20-06-24
Director/Board Member 55 21-05-26
More insiders
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
83.85 EUR
Average target price
103.9 EUR
Spread / Average Target
+23.87%
Consensus